Point72 Hong Kong LTD Moderna, Inc. Transaction History

Point72 Hong Kong LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $1.23 Million - $2 Million	-5,433 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $1.21 Million - $2.63 Million	5,433 New	5,433 $2.09 Million
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $181,784 - $309,656	-1,665 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $1.41 Million - $3.64 Million	-21,447 Reduced 92.8%	1,665 $174,000
Q3 2020 Nov 16, 2020	BUY	$54.34 - $94.85 $1.26 Million - $2.19 Million	23,112 New	23,112 $1.64 Million
Q1 2019 May 15, 2019	SELL	$14.45 - $23.7 $481,459 - $789,660	-33,319 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$13.52 - $18.8 $450,472 - $626,397	33,319 New	33,319 $509,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.